COMP <GO>
KROS vs ELDN // RETURN ON INVESTED CAPITAL (ROIC)
Keros Therapeutics Inc. (NASDAQ) VS. Eledon Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: KROS 3
— ELDN 1
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: KROS
LAST: $10.76 (-2.54%) • MKT CAP: $213.3M
roic
85.00%
LAST: $2.62 (-5.41%) • MKT CAP: $212.9M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KROS VS. ELDN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KROS | ELDN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 85.00% | -35.00% | +120.00 | KROS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 27.70% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 35.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.31 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 1/9 | +7.00 | KROS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 51.0 | -7.50 | ELDN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $213.3M | $212.9M | $436.3K | KROS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KROS REV | ELDN REV | KROS GROSS % | ELDN GROSS % | KROS FCF | ELDN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $244.1M | $71.0M | — | — | $106.0M | -$62.3M |
| FY 2024 | $3.5M | $74.5M | — | — | -$162.8M | -$47.3M |
| FY 2023 | $151.0K | $120.4M | — | — | -$124.5M | -$39.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KROS // BETA —
ELDN // BETA —